0
Skip to Content
Bleecker Street Research
Bleecker Street Research
About
Research
Contact
Bleecker Street Research
Bleecker Street Research
About
Research
Contact
About
Research
Contact

Subscribe to receive short ideas in your inbox:

Thank you!
Credit Rejectance (CACC)
Chris Drose 1/13/23 Chris Drose 1/13/23

Credit Rejectance (CACC)

Read More
Energy Vault (NRGV): New Evidence Leads Us To Downgrade This Company To A Middle-School Science Fair Project
Chris Drose 12/2/22 Chris Drose 12/2/22

Energy Vault (NRGV): New Evidence Leads Us To Downgrade This Company To A Middle-School Science Fair Project

Read More
Joby Aviation (JOBY): “Uber Meets Tesla In The Sky” Is Set To Crash And Burn
Chris Drose 9/29/22 Chris Drose 9/29/22

Joby Aviation (JOBY): “Uber Meets Tesla In The Sky” Is Set To Crash And Burn

Read More
Hall of Fame Resort and Entertainment (HOFV) Update: Something Stinks In Stark County
Chris Drose 8/12/22 Chris Drose 8/12/22

Hall of Fame Resort and Entertainment (HOFV) Update: Something Stinks In Stark County

Read More
In The Shadow of Slavery and Dirty Coal: How Daqo New Energy Became The World’s Lowest Cost Polysilicon Producer
Chris Drose 1/24/22 Chris Drose 1/24/22

In The Shadow of Slavery and Dirty Coal: How Daqo New Energy Became The World’s Lowest Cost Polysilicon Producer

Read More
Alfi (ALF): Miami’s First Tech IPO Is Quintessential Florida; An Ad-Tech Company With A Questionable C-Suite, “Continuing” Buy-Backs, And Relying On A Laser Engraving Company For Distribution.
Chris Drose 9/2/21 Chris Drose 9/2/21

Alfi (ALF): Miami’s First Tech IPO Is Quintessential Florida; An Ad-Tech Company With A Questionable C-Suite, “Continuing” Buy-Backs, And Relying On A Laser Engraving Company For Distribution.

Read More
Asensus Surgical (ASXC): A New Name Can’t Change a History of Failure, Evidence of a Failed Commercialization, and Enormous Losses
Chris Drose 8/4/21 Chris Drose 8/4/21

Asensus Surgical (ASXC): A New Name Can’t Change a History of Failure, Evidence of a Failed Commercialization, and Enormous Losses

Read More
Hall of Fame Village (HOFV): Not the Disney World Of Football, Merely a Midwestern Mirage
Chris Drose 6/30/21 Chris Drose 6/30/21

Hall of Fame Village (HOFV): Not the Disney World Of Football, Merely a Midwestern Mirage

Read More
Retractable Technologies (RVP): Insider Enrichment Schemes, Operation Warp Speed Contracts, and a $54 million Technology Investment Agreeement
Chris Drose 4/23/21 Chris Drose 4/23/21

Retractable Technologies (RVP): Insider Enrichment Schemes, Operation Warp Speed Contracts, and a $54 million Technology Investment Agreeement

Read More
DS Healthcare (DSKX): Look For 60-70% Drop On Equity Offering, Accounting Problems, And Solvency Concerns
Chris Drose 8/17/15 Chris Drose 8/17/15

DS Healthcare (DSKX): Look For 60-70% Drop On Equity Offering, Accounting Problems, And Solvency Concerns

Read More
Chanticleer Holdings (HOTR): Could Fall 60% After Stock Promotion Becomes Clear
Chris Drose 6/8/15 Chris Drose 6/8/15

Chanticleer Holdings (HOTR): Could Fall 60% After Stock Promotion Becomes Clear

Read More
American Addiction Centers (AAC): Addicted to Fraudulent Drug Testing
Chris Drose 3/3/15 Chris Drose 3/3/15

American Addiction Centers (AAC): Addicted to Fraudulent Drug Testing

Read More
Cellceutix (CTIX): A December To Remember May Turn Into A 2015 To Forget
Chris Drose 1/23/15 Chris Drose 1/23/15

Cellceutix (CTIX): A December To Remember May Turn Into A 2015 To Forget

Read More
Vimicro (VIMC): Numerous Red Flags Make This A Strong Sell
Chris Drose 10/7/14 Chris Drose 10/7/14

Vimicro (VIMC): Numerous Red Flags Make This A Strong Sell

Read More
China Finance Online (JRJC): This Did Not End Well Last Time
Chris Drose 8/28/14 Chris Drose 8/28/14

China Finance Online (JRJC): This Did Not End Well Last Time

Read More
China Finance Online (JRJC): Shares Soar On Over-Hyped Deal, More Questions Than Answers
Chris Drose 8/20/14 Chris Drose 8/20/14

China Finance Online (JRJC): Shares Soar On Over-Hyped Deal, More Questions Than Answers

Read More
Galectin Therapeutics (GALT): Why This Penny Stock Dressed Up By Stock Promoters Is A Short
Chris Drose 7/28/14 Chris Drose 7/28/14

Galectin Therapeutics (GALT): Why This Penny Stock Dressed Up By Stock Promoters Is A Short

Read More
Newer Posts

Subscribe to get Bleecker Street Research reports in your inbox.

Thank you!

Bleecker Street Research
info@bleeckerstcapital.com